๐Ÿ“–
First Report of Real World Utilization of an Activin Signaling Inhibitor in Patients With Severe Pulmonary Arterial Hypertension in the Middle East PH RISE-ME Study.
Jabi MA, Sabbour H, Mohamed L, Alsultan S, Almassabi M, Osama M, Abudouleh A, Sondoqah M, Zaki MK, Hesham A, Saleh KM, Haque MUI, Preston I

First Report of Real World Utilization of an Activin Signaling Inhibitor in Patients With Severe Pulmonary Arterial Hypertension in the Middle East PH RISE-ME Study.

Medicine & Health Published 2026 Verification Pending

Overview & Synopsis

Open access biomedical research article published in Pulm Circ.

Advertisement
SPONSOR CONTENT
Indexed from repository: PubMed Central (pmc.ncbi.nlm.nih.gov)
Loading document from verified source...
Keyboard Shortcuts: ← / → for pages • + / - for zoom • 0 to fit width Powered by Mozilla PDF.js v3.11

Document Information

Document Title First Report of Real World Utilization of an Activin Signaling Inhibitor in Patients With Severe Pulmonary Arterial Hypertension in the Middle East PH RISE-ME Study.
Author / Organization Jabi MA, Sabbour H, Mohamed L, Alsultan S, Almassabi M, Osama M, Abudouleh A, Sondoqah M, Zaki MK, Hesham A, Saleh KM, Haque MUI, Preston I
Subject & Discipline Pulm Circ
Categories Medicine & Health
Publication Year 2026
License / Rights Open Access / Creative Commons
Resource Verification Listed PDF (Verification Pending)
Original Host Website PubMed Central (pmc.ncbi.nlm.nih.gov)
File Format application/pdf (Portable Document Format)
Language EN
Catalog ID DOC-48341
Original Source Link Visit Source Page on pmc.ncbi.nlm.nih.gov »